CA2496918A1 - Procedes chromatographiques de purification d'adenovirus - Google Patents
Procedes chromatographiques de purification d'adenovirus Download PDFInfo
- Publication number
- CA2496918A1 CA2496918A1 CA002496918A CA2496918A CA2496918A1 CA 2496918 A1 CA2496918 A1 CA 2496918A1 CA 002496918 A CA002496918 A CA 002496918A CA 2496918 A CA2496918 A CA 2496918A CA 2496918 A1 CA2496918 A1 CA 2496918A1
- Authority
- CA
- Canada
- Prior art keywords
- medium
- adenovirus
- media
- cells
- chromatographic medium
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
- C12N15/86—Viral vectors
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/10011—Adenoviridae
- C12N2710/10311—Mastadenovirus, e.g. human or simian adenoviruses
- C12N2710/10341—Use of virus, viral particle or viral elements as a vector
- C12N2710/10343—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/10011—Adenoviridae
- C12N2710/10311—Mastadenovirus, e.g. human or simian adenoviruses
- C12N2710/10351—Methods of production or purification of viral material
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Genetics & Genomics (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Biomedical Technology (AREA)
- General Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Virology (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Plant Pathology (AREA)
- Biophysics (AREA)
- Physics & Mathematics (AREA)
- Molecular Biology (AREA)
- Immunology (AREA)
- Medicinal Chemistry (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
L'invention concerne des procédés permettant de faire passer des préparations de particules d'adénovirus à travers un milieu chromatographique afin de fournir des particules d'adénovirus purifiées.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US40659102P | 2002-08-28 | 2002-08-28 | |
US60/406,591 | 2002-08-28 | ||
PCT/US2003/026831 WO2004020971A2 (fr) | 2002-08-28 | 2003-08-27 | Procedes chromatographiques de purification d'adenovirus |
Publications (1)
Publication Number | Publication Date |
---|---|
CA2496918A1 true CA2496918A1 (fr) | 2004-03-11 |
Family
ID=31978321
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA002496918A Abandoned CA2496918A1 (fr) | 2002-08-28 | 2003-08-27 | Procedes chromatographiques de purification d'adenovirus |
Country Status (5)
Country | Link |
---|---|
US (1) | US20040106184A1 (fr) |
EP (1) | EP1585964A4 (fr) |
AU (1) | AU2003268210A1 (fr) |
CA (1) | CA2496918A1 (fr) |
WO (1) | WO2004020971A2 (fr) |
Families Citing this family (54)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP4492826B2 (ja) * | 1996-11-20 | 2010-06-30 | イントロジェン セラピューティクス,インコーポレイテッド | アデノウイルスベクターの産生および精製のための改良された方法 |
US20040229335A1 (en) * | 2003-05-15 | 2004-11-18 | Introgen Therapeutics, Inc. | Methods and compositions for the production of adenoviral vectors |
ES2382557T3 (es) | 2004-12-23 | 2012-06-11 | Medimmune, Llc | Línea celular MDCK no tumorigénica para propagar virus |
JP5215672B2 (ja) * | 2005-03-04 | 2013-06-19 | ノースウェスタン ユニバーシティ | 密度勾配によるカーボンナノチューブの分離 |
CA2599754C (fr) * | 2005-03-08 | 2012-06-19 | Genesense Technologies Inc. | Utilisation de l'interleukine 17e pour le traitement du cancer |
EP1736538A1 (fr) | 2005-06-21 | 2006-12-27 | Cytos Biotechnology AG | Procédé pour la purification préparative de particules pseudo-virales (VLPs) |
WO2007059473A2 (fr) * | 2005-11-12 | 2007-05-24 | Introgen Therapeutics, Inc. | Procedes de production et de purification de vecteurs adenoviraux |
CN104163413B (zh) | 2006-08-30 | 2016-08-24 | 西北大学 | 单分散单壁碳纳米管群体及其制造方法 |
BRPI0716724A2 (pt) | 2006-09-15 | 2013-10-01 | Medimmune Llc | cÉlula renal canina de madin-darby, e, mÉtodos para proliferar a mesma, para produzir vÍrus da influenza adaptados ao frio e apra eliminar contaminantes de dna de uma preparaÇço viral |
KR20170001720A (ko) | 2007-03-14 | 2017-01-04 | 다케다 백신즈 인코포레이티드 | 바이러스 유사 입자 정제 |
WO2009123657A1 (fr) * | 2008-04-01 | 2009-10-08 | University Of North Carolina At Charlotte | Ensemble bioréacteur et procédés associés |
SG194372A1 (en) * | 2008-09-24 | 2013-11-29 | Medimmune Llc | Methods for cultivating cells, propagating and purifying viruses |
EP3591059B1 (fr) * | 2009-03-02 | 2022-07-20 | The Regents of The University of California | Mutants e1b et e1a sélectifs de tumeurs |
WO2010130756A1 (fr) | 2009-05-12 | 2010-11-18 | Transgene Sa | Lignées cellulaires aviaires immortalisées et applications associées |
US8771709B2 (en) | 2010-09-20 | 2014-07-08 | Crucell Holland B.V. | Therapeutic vaccination against active Tuberculosis |
US9168292B2 (en) | 2010-09-27 | 2015-10-27 | Crucell Holland B.V. | Heterologous prime boost vaccination regimen against malaria |
TR201810703T4 (tr) * | 2011-03-25 | 2018-08-27 | Hoffmann La Roche | Yeni protein saflaştırma yöntemleri. |
EP3210662A1 (fr) * | 2011-06-08 | 2017-08-30 | Agency For Science, Technology And Research | Purification de produits biologiques par chromatographie avec cohydratation forcée |
US20130122038A1 (en) | 2011-11-14 | 2013-05-16 | The United States Of America As Represented By The Secretary Of The Department | Heterologous prime-boost immunization using measles virus-based vaccines |
NZ628385A (en) | 2012-03-12 | 2016-09-30 | Crucell Holland Bv | Batches of recombinant adenovirus with altered terminal ends |
US8932607B2 (en) | 2012-03-12 | 2015-01-13 | Crucell Holland B.V. | Batches of recombinant adenovirus with altered terminal ends |
US9125870B2 (en) | 2012-03-22 | 2015-09-08 | Crucell Holland B.V. | Vaccine against RSV |
NZ630649A (en) | 2012-03-22 | 2016-12-23 | Janssen Vaccines & Prevention Bv | Vaccine against rsv |
JOP20130186B1 (ar) | 2012-06-22 | 2021-08-17 | Takeda Vaccines Montana Inc | تنقية الجزيئات الشبيهة بالفيروسات |
CA2901025C (fr) * | 2013-03-12 | 2021-01-26 | Indian Council Of Medical Research | Procede de production de cyclosporine-a (cyc-a) au moyen du champignon tolypocladium sp., souche nrrl n° 18950 |
EP2988780B1 (fr) | 2013-04-25 | 2018-12-26 | Janssen Vaccines & Prevention B.V. | Polypeptides préfusion rsv f solubles et stabilisée |
CN105408348B (zh) | 2013-06-17 | 2021-07-06 | 扬森疫苗与预防公司 | 稳定化的可溶性融合前rsv f多肽 |
EP3054007A1 (fr) * | 2015-02-09 | 2016-08-10 | Institut National De La Sante Et De La Recherche Medicale (Inserm) | Purification de particules de virus adéno-associés de recombinaison comprenant une étape de purification par affinité immunologique |
EP3054006A1 (fr) | 2015-02-09 | 2016-08-10 | Institut National De La Sante Et De La Recherche Medicale (Inserm) | Purification de particule de virus adéno-associé recombinant avec une chromatographie à échange d'anions en plusieurs étapes |
EP3283634B1 (fr) | 2015-04-14 | 2019-05-22 | Janssen Vaccines & Prevention B.V. | Adénovirus recombinant exprimant deux transgènes comprenant un promoteur bidirectionnel |
PL3319633T3 (pl) | 2015-07-07 | 2021-04-19 | Janssen Vaccines & Prevention B.V. | Szczepionka przeciwko rsv |
KR20180026734A (ko) | 2015-07-07 | 2018-03-13 | 얀센 백신스 앤드 프리벤션 비.브이. | 안정화된 가용성 융합-전 rsv f 폴리펩티드 |
US9663766B2 (en) * | 2015-07-24 | 2017-05-30 | Bio-Rad Laboratories, Inc. | Methods for purifying adenovirus vectors |
MX2018012095A (es) | 2016-04-05 | 2019-01-10 | Janssen Vaccines & Prevention Bv | Vacuna contra vrs. |
WO2017174568A1 (fr) | 2016-04-05 | 2017-10-12 | Janssen Vaccines & Prevention B.V. | Protéines f du vrs de pré-fusion solubles stabilisées |
JP7046835B2 (ja) | 2016-05-12 | 2022-04-04 | ヤンセン ファッシンズ アンド プリベンション ベーフェー | 強力でバランスのとれた双方向性プロモーター |
DK3464331T3 (da) | 2016-05-30 | 2021-01-18 | Janssen Vaccines & Prevention Bv | Stabiliserede præfusions-rsv f-proteiner |
BR112018075969A2 (pt) | 2016-06-20 | 2019-04-02 | Janssen Vaccines & Prevention B.V. | promotor bidirecional potente e equilibrado |
JP7229151B2 (ja) | 2016-07-14 | 2023-02-27 | ヤンセン ファッシンズ アンド プリベンション ベーフェー | Hpvワクチン |
GB201612248D0 (en) * | 2016-07-14 | 2016-08-31 | Puridify Ltd | New process |
EA201990317A1 (ru) | 2016-08-16 | 2019-07-31 | Ридженерон Фармасьютикалз, Инк. | Способы определения количества индивидуальных антител из смеси |
ES2924060T3 (es) | 2016-10-25 | 2022-10-04 | Regeneron Pharma | Procedimientos y sistema para análisis de datos de cromatografía |
US11034978B2 (en) | 2017-02-09 | 2021-06-15 | Janssen Vaccines & Prevention B.V. | Potent and short promoter for expression of heterologous genes |
JP2020519663A (ja) | 2017-05-17 | 2020-07-02 | ヤンセン ファッシンズ アンド プリベンション ベーフェーJanssen Vaccines & Prevention B.V. | Rsv感染に対する防御免疫を誘導するための方法及び組成物 |
EP3681533A1 (fr) | 2017-09-15 | 2020-07-22 | Janssen Vaccines & Prevention B.V. | Procédé d'induction sûre de l'immunité contre le vrs |
US11603527B2 (en) * | 2017-12-27 | 2023-03-14 | Global Life Sciences Solutions Usa Llc | Method and kit for viral vector isolation |
CN108593823B (zh) * | 2018-04-04 | 2020-10-09 | 桂林理工大学 | 一种分离富集大体积水样中三嗪类农药的方法 |
TW202005694A (zh) | 2018-07-02 | 2020-02-01 | 美商里珍納龍藥品有限公司 | 自混合物製備多肽之系統及方法 |
US20220090140A1 (en) * | 2019-05-14 | 2022-03-24 | Janssen Biotech, Inc. | Efficient Impurity Removal Using A Diafiltration Process |
CN114173827A (zh) * | 2019-06-28 | 2022-03-11 | 武田药品工业株式会社 | 腺相关病毒纯化方法 |
CN110714029A (zh) * | 2019-11-06 | 2020-01-21 | 无锡生基医药科技有限公司 | 一种慢病毒载体全封闭生产的方法及系统 |
CL2020002629A1 (es) | 2020-10-12 | 2021-01-15 | Taag Genetics S A | Nuevo dispositivo de biología molecular para extracción y purificación de ácidos nucleicos desde diferentes tipos de muestras biológicas que comprende resinas de adsorción |
CN113416235B (zh) * | 2021-06-24 | 2023-04-25 | 苏州赛分科技股份有限公司 | 用于纯化分离病毒类抗原的液相色谱法 |
CN114317464B (zh) * | 2021-12-27 | 2023-07-04 | 武汉汇研生物科技股份有限公司 | 腺相关病毒rAAV9的分离纯化方法 |
Family Cites Families (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4352883A (en) * | 1979-03-28 | 1982-10-05 | Damon Corporation | Encapsulation of biological material |
EP0571014B1 (fr) * | 1992-05-18 | 2004-03-31 | Genencor International, Inc. | Bactéries produisant des protéases alcalines et production de ces protéases alcalines |
US5837520A (en) * | 1995-03-07 | 1998-11-17 | Canji, Inc. | Method of purification of viral vectors |
US5744304A (en) * | 1995-05-30 | 1998-04-28 | Board Of Regents, The University Of Texas System | Inflammation-induced expression of a recombinant gene |
CA2625279A1 (fr) * | 1995-08-30 | 1997-03-06 | Genzyme Corporation | Purification d'adenovirus et de virus adeno-associe (aav) par voie chromatographique |
DE69636120T2 (de) * | 1995-11-30 | 2006-11-30 | The Board of Regents, The University of Texas System, Austin | Verfahren und zusammensetzungen zur behandlung von krebs |
US6485958B2 (en) * | 1996-07-01 | 2002-11-26 | Gencell Sa | Method for producing recombinant adenovirus |
US7732129B1 (en) * | 1998-12-01 | 2010-06-08 | Crucell Holland B.V. | Method for the production and purification of adenoviral vectors |
JP4492826B2 (ja) * | 1996-11-20 | 2010-06-30 | イントロジェン セラピューティクス,インコーポレイテッド | アデノウイルスベクターの産生および精製のための改良された方法 |
US6261823B1 (en) * | 1996-12-13 | 2001-07-17 | Schering Corporation | Methods for purifying viruses |
WO1999061643A1 (fr) * | 1998-05-27 | 1999-12-02 | University Of Florida | Procede de preparation de compositions de virus adeno-associes de recombinaison a l'aide d'un gradient d'iodixananol |
AU740441B2 (en) * | 1998-06-30 | 2001-11-01 | La Mina Ltd | Cytological and histological fixative composition and methods of use |
-
2003
- 2003-08-27 US US10/649,974 patent/US20040106184A1/en not_active Abandoned
- 2003-08-27 EP EP03749161A patent/EP1585964A4/fr not_active Withdrawn
- 2003-08-27 AU AU2003268210A patent/AU2003268210A1/en not_active Abandoned
- 2003-08-27 CA CA002496918A patent/CA2496918A1/fr not_active Abandoned
- 2003-08-27 WO PCT/US2003/026831 patent/WO2004020971A2/fr not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
EP1585964A2 (fr) | 2005-10-19 |
WO2004020971A2 (fr) | 2004-03-11 |
US20040106184A1 (en) | 2004-06-03 |
WO2004020971A3 (fr) | 2007-11-08 |
EP1585964A4 (fr) | 2008-07-16 |
AU2003268210A8 (en) | 2004-03-19 |
AU2003268210A1 (en) | 2004-03-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CA2496918A1 (fr) | Procedes chromatographiques de purification d'adenovirus | |
CA2353787C (fr) | Procede ameliore de production et de purification de vecteurs adenoviraux | |
US7445930B2 (en) | Method for the production and purification of adenoviral vectors | |
US20060166364A1 (en) | Use of flexible bag containers for viral production | |
WO1998022588A9 (fr) | Procede ameliore pour production et purification de vecteurs d'adenovirus | |
US7419808B2 (en) | Methods and compositions for the production of adenoviral vectors | |
WO2007059473A2 (fr) | Procedes de production et de purification de vecteurs adenoviraux | |
WO1999027123A9 (fr) | Vecteurs viraux sv40 modifies |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
EEER | Examination request | ||
FZDE | Dead |